US President Donald Trump wants to peg US in-patient drug prices to an international drug price index, comprising mostly European countries. He is calling for an end to other countries’ “freeloading” off the US, which has the highest drug prices in the wo
When Vectura’s nebulised form of budesonide, VR475, failed its Phase III asthma trial in late November 2018, the UK company blamed the drug, not the device. A conventional nebulizer also failed to significantly impact exacerbations, versus placebo.
It’s November, and if the men around you are sporting especially robust moustaches, don’t worry. It means they are paying attention to their health. During Movember--a mashup of “moustache” and “November”--men grow out their moustaches to raise awareness
LEO Pharma’s November 2018 deal with rare disease play PellePharm, worth up to $760 million, is just one recent example of the value that orphan drug assets can command. PellePharm’s lead candidate, patidegib, treats a little-known skin disease called Gor